We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

COVID-19 Trial of Remdesivir Suggests It Is Not Associated With Significant Clinical Benefits, More Research Needed

News   Apr 30, 2020 | Original story from The Lancet

 
COVID-19 Trial of Remdesivir Suggests It Is Not Associated With Significant Clinical Benefits, More Research Needed
 
 
Advertisement
 

RELATED ARTICLES

Oropharyngeal Secretions May Help To Reduce False Negative COVID-19 Test Results

News

A new study published in the Journal of Dental Research demonstrates that testing of oropharyngeal secretions may reduce the number of false negative results from nasal swab testing of COVID-19 patients.

READ MORE

Oat and Rye Bran Boost Gut Microbiome and Benefit Health

News

Consumption of dietary fiber from oat and rye brans supported the growth of beneficial gut microbiota, which in turn benefited cholesterol levels, weight gain, liver inflammation and gut health.

READ MORE

Chemo Drug May Be Less Effective in Overweight Women With Breast Cancer

News

Breast cancer patients who are overweight or obese might benefit less from treatment with a common chemotherapy drug, called docetaxel.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE